Decreased Serum Hepatocyte Growth Factor (HGF) in Individuals with Depression Correlates with Severity of Disease
A.J. RussoResearch Director, Health Research Institute/Pfeiffer Treatment Center, Warrenville, Illinois 60555, USA. Abstract Aim: To assess serum Hepatocyte Growth Factor (HGF) levels in individuals with depression and to test the hypothesis that there is a relationship between severity of depressio...
Gespeichert in:
Veröffentlicht in: | Biomarker insights 2010, Vol.2010 (5), p.BMI.S5183-67 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A.J. RussoResearch Director, Health Research Institute/Pfeiffer Treatment Center, Warrenville, Illinois 60555, USA. Abstract Aim: To assess serum Hepatocyte Growth Factor (HGF) levels in individuals with depression and to test the hypothesis that there is a relationship between severity of depression and HGF concentration.Subjects and methods: Serum from 26 clinically depressed individuals and 19 controls were tested for serum HGF using ELISAs. Correlation was established between HGF concentration and disease severity.Results: Depressed individuals had significantly lower serum levels of HGF compared to controls (P < 0.0001). HGF concentration correlated with overall depressive behavior (P = 0.03) and specifically depression (P = 0.02), but not anxiety (P = 0.36).Discussion: These results suggest an association between HGF serum levels and clinically depressed individuals and demonstrate a correlation between severity of depression and HGF levels. Further studies of the predictive strength of HGF as a biomarker for depression may be warranted. |
---|---|
ISSN: | 1177-2719 1177-2719 |
DOI: | 10.4137/BMI.S5183 |